Call for evidence on possible restriction proposal for MOCA
We are collecting further information for a potential restriction proposal on
4,4'-methylenebis[2-chloroaniline] (MOCA).
MOCA is on the REACH Authorisation List and we have screened its uses and their risks in products (articles) as required by Article 69(2). We are now looking for information to see whether a restriction proposal needs to be prepared to control the risks to people from this carcinogen that has no safe level of exposure.
The deadline for comments is 16 November 2022.
Current calls for comments and evidence
Last call: Consultation on EFSA's data on game meat
Send us your comments by 6 October 2022 on two European Food Safety Authority (EFSA) datasets on game meat intake and lead concentrations in game meat. This data was used by ECHA to assess the risks to human health from the use of lead in ammunition.
Give comments
Register now: Workshop on using trivalent chromium in functional plating with decorative character
10 October 2022, 13:00-16:00 Brussels time
We are organising an online workshop together with industry to understand:
-
How trivalent chromium is currently used in functional plating with decorative character, and to what extent are borates used in this process?
-
What are the implications on human health and the environment from using trivalent chromium and borates?
-
What sources are used to manufacture trivalent chromium and how is this is different from hexavalent chromium?
The workshop will be organised through WebEx. Register now to book your seat. Login details will be sent to those who register.
Register | More
Assessment of regulatory needs reports published
Reports have been published for the following groups of substances:
You can filter the list with the group name to get a full list of the substances in the group and access the report.
Assessment of regulatory needs
Authorisations granted for uses of two substances
The European Commission has granted an authorisation for uses of chromium trioxide (EC 215-607-8, CAS 1333-82-0) to Salzgitter Flachstahl GmbH (review period expires on 31 December 2032).
The European Commission has granted 2 authorisations for uses of 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
(EC -, CAS -) (review period expiry dates in brackets):
-
one use applied for by LETI Pharma, S.L.U. (31 December 2030); and
-
one use applied for by Vetter Pharma-Fertigung GmbH & Co. KG
(4 January 2026).
|